2008 U.S. Inflammatory Diseases Drug Delivery: Physician Perspective

Frost & Sullivan
November 1, 2010
45 Pages - SKU: MC2873701
Countries covered: United States



This study encompasses feedback provided by U.S. physicians who treat inflammatory diseases on aspects of drug delivery and drug treatment, enabling interested stakeholders to gain insight into current and future trends. Analysis includes issues such as awareness, usage, preferences, influencing criteria, patient compliance, desired delivery types to be made available, as well as feedback on the role the device plays in the prescribing decision for a drug. The corresponding patient deliverable is titled: "2008 U.S. Inflammatory Diseases Drug Delivery: Patient Perspective" (N835).



More Drug Delivery reports by Frost & Sullivan

Advancement in Liquid Dosage Excipients (Parenteral & Transdermal) by Frost & Sullivan
Advancement in Liquid Dosage Excipients (Parenteral & Transdermal) Executive Summary In 2013, the global parenteral excipients segment generated a revenue of $?? million, and ...
Breakthroughs in Ophthalmic Devices and Drug Delivery Technologies (Technical Insights) by Frost & Sullivan
Breakthroughs in Ophthalmic Devices and Drug Delivery Technologies (Technical Insights) The aging of the population around the world will consequently lead to a rapid ...
United States Oncology Drug Delivery Preferences and Opportunities in Cancer Drug Delivery by Frost & Sullivan
Drug delivery is an important area of drug development in the pharmaceutical and biotechnology industry. In Oncology, developers are interested in understanding the opportunities and ...
2009 United States Oncology Drug Delivery Patterns, Preferences, and Opportunities by Frost & Sullivan
Drug delivery is an important area of drug development in the pharmaceutical and biotechnology industry. This customer research was completed to understand trends, dynamics, and ...
See all reports like this >>

More United States Drug Delivery reports

U.S. Market for Diabetes Monitoring, Treatment and Drug Delivery 2014 by iData Research, Inc.
Abstract:According to the Center for Disease Control and Prevention (CDC), diabetes is the seventh leading cause of death among Americans as of 2014. Moreover, diagnosed ...
The 2013-2018 Outlook for Pulmonary Drug Delivery Technologies in the United States by Icon Group International, Inc.
The 2013-2018 Outlook for Pulmonary Drug Delivery Technologies in the United StatesThis econometric study covers the latent demand outlook for pulmonary drug delivery technologies across ...
The 2013-2018 Outlook for Intranasal Drug Delivery Applications in the United States by Icon Group International, Inc.
The 2013-2018 Outlook for Intranasal Drug Delivery Applications in the United StatesThis econometric study covers the latent demand outlook for intranasal drug delivery applications across ...
Nanotechnology Drug Delivery Market in the US 2012-2016 by TechNavio - Infiniti Research Ltd.
TechNavio's analysts forecast the Nanotechnology Drug Delivery market in the US to grow at a CAGR of 84.79 percent over the period 2012-2016. One of ...
See all reports like this >>

More United States reports

The 2013-2018 Outlook for Collagen and (hyaluronic Acid) HA-Based Biomaterials in the United States by Icon Group International, Inc.
The 2013-2018 Outlook for Collagen and (hyaluronic Acid) HA-Based Biomaterials in the United StatesThis econometric study covers the latent demand outlook for collagen and (hyaluronic ...
The 2013-2018 Outlook for Relish in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for relish across the states and cities of the United States. Latent demand (in millions of U.S. ...
D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United States of America by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
See all reports like this >>

 

SELECT A LICENSE

    Electronic Access
Single User Fulfilled By Publisher
  USD 10,000  
    Electronic Access
Global Site License Fulfilled By Publisher
  USD 11,500  
    Hard Copy Mail Delivery  USD 10,500  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!